SUMMARY OF SCREENING DATA FROM 19 PATIENTS WITH LATE-ONSET POMPE DISEASE FOR A PHASE I CLINICAL TRIAL OF AAV VECTOR-MEDIATED GENE THERAPY

被引：0
|
作者：
Hannah, William B. [1 ]
Case, Laura E. [2 ]
Walters, Crista [1 ]
Kishnani, Priya S. [1 ]
Koeberl, Dwight D. [1 ]
机构：
[1] Duke Univ, Sch Med, Dept Pediat, Div Med Genet, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Phys & Occupat Therapy, Durham, NC USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2019年 / 127卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
67
引用
收藏
页码：274 / 274
页数：1
相关论文
共 50 条
  • [1] SUMMARY OF SCREENING DATA FROM 19 PATIENTS WITH LATE-ONSET POMPE DISEASE FOR A PHASE I CLINICAL TRIAL OF AAV VECTOR-MEDIATED GENE THERAPY
    Hannah, William B.
    Case, Laura E.
    Walters, Crista
    Kishnani, Priya S.
    Koeberl, Dwight D.
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 305 - 306
  • [2] Phase I study of liver depot gene therapy in late-onset Pompe disease
    Smith, Edward C.
    Hopkins, Sam
    Case, Laura E.
    Xu, Ming
    Walters, Crista
    Dearmey, Stephanie
    Han, Sang -oh
    Spears, Tracy G.
    Chichester, Jessica A.
    Bossen, Edward H.
    Hornik, Christoph P.
    Cohen, Jennifer L.
    Bali, Deeksha
    Kishnani, Priya S.
    Koeberl, Dwight D.
    MOLECULAR THERAPY, 2023, 31 (07) : 1994 - 2004
  • [3] Efficacious Androgen Hormone Administration in Combination with AAV Vector-Mediated Gene Therapy in Female Mice with Pompe Disease
    Han, Sang-oh
    Mapatano, Sweet Hope
    Li, Songtao
    Brooks, Elizabeth
    Koeberl, Dwight
    MOLECULAR THERAPY, 2017, 25 (05) : 193 - 194
  • [4] Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease
    Wang, Gensheng
    Young, Sarah P.
    Bali, Deeksha
    Hutt, Julie
    Li, Songtao
    Benson, Janet
    Koeberl, Dwight D.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2014, 1 : 14018
  • [5] Assessment of Toxicity and Biodistribution of an AAV2/8 Vector-Mediated Immunomodulatory Gene Therapy in Mice With Pompe Disease
    Han, Sang-oh
    Wang, Gensheng
    Young, Sarah
    Bali, Deeksha
    Benson, Janet
    Koeberl, Dwight
    MOLECULAR THERAPY, 2014, 22 : S19 - S19
  • [6] A phase 1 study of gene therapy with ACTUS-101 in late-onset Pompe disease
    Koeberl, Dwight
    Smith, Edward C.
    Case, Laura E.
    Hopkins, Sam
    Childers, Martin K.
    Walters, Crista
    Han, Sang-oh
    Spears, Tracy G.
    Hornik, Christoph P.
    Bali, Deeksha
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S91 - S91
  • [7] Early clinical phenotype of late-onset Pompe disease: Lessons learned from newborn screening
    Huggins, Erin
    Holland, Maggie
    Case, Laura E.
    Blount, Janet
    Landstrom, Andrew P.
    Jones, Harrison N.
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S57 - S57
  • [8] Clinical course of seven patients with late-onset Pompe disease receiving enzyme replacement therapy
    Spranger, M.
    Grunert, B.
    CLINICAL THERAPEUTICS, 2007, 29 : S120 - S121
  • [9] Phase 1 Study of Gene Therapy in Late-Onset Pompe Disease: Analyses of Safety and Secondary Endpoints
    Koeberl, Dwight
    Smith, Edward C.
    Case, Laura
    Hopkins, Sam
    Childers, Martin K.
    Dearmey, Stephanie
    Walters, Crista
    Han, Sang-oh
    Spears, Tracy G.
    Hornik, Christoph P.
    Bali, Deeksha
    Kishnani, Priya S.
    MOLECULAR THERAPY, 2020, 28 (04) : 224 - 224
  • [10] A phase 1/2 clinical trial for AAV8-mediated liver-directed gene therapy in adults with late-onset OTC deficiency
    Geberhiwot, T.
    Aldamiz-Echevarria, L.
    Couce, M. L.
    Harding, C. O.
    Khan, A.
    Tan, W. H.
    Lin, J.
    Crombez, E.
    Diaz, G. A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A59 - A59
12345